Venue

DZNE was founded in 2009 as a member of the Helmholtz Association and the first member of the German Centers for Health Research (DZG). Today, it consists of ten sites – Berlin, Bonn, Dresden, Göttingen, Magdeburg, Munich, Rostock/Greifswald, Tübingen, Ulm and Witten – and pools expertise distributed nationwide within a single research institute. More than 1,200 professionals collaborate to understand the causes of diseases of the nervous system and to find novel approaches for effective prevention, therapy, and patient care. Worldwide, DZNE is one of the largest research institutes dedicated to these topic. It is funded by the German Federal Ministry of Education and Research (BMBF) and by the federal states in which DZNE sites are located. DZNE is involved in the implementation of the National Dementia Strategy for Germany.

Research at DZNE aims at preventing neurodegeneration and significantly improve the quality of life of affected individuals. Thus, DZNE dedicates its efforts towards all aspects of neurodegenerative diseases – from molecular mechanisms to health care and patient care. In order to cover this wide range of topics, DZNE pursues an interdisciplinary scientific strategy that includes various interlinked areas of research: DZNE scientists work together across disciplines and sites, so that new findings can be rapidly transferred into practical application. Within this “translational” approach, DZNE collaborates with universities, university hospitals, research institutes and research-driven companies – both in Germany and worldwide.